| Antiangiogenic effects of flavonoids and chalcones J Mojzis, L Varinska, G Mojzisova, I Kostova, L Mirossay Pharmacological research 57 (4), 259-265, 2008 | 348 | 2008 |
| Soy and breast cancer: focus on angiogenesis L Varinska, P Gal, G Mojzisova, L Mirossay, J Mojzis International journal of molecular sciences 16 (5), 11728-11749, 2015 | 214 | 2015 |
| Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats A Lukačínová, J Mojžiš, R Beňačka, J Keller, T Maguth, P Kurila, L Vaško, ... Acta Veterinaria Brno 77 (2), 175-182, 2008 | 192 | 2008 |
| Effects of static magnetic field on human leukemic cell line HL-60 J Sabo, L Mirossay, L Horovcak, M Sarissky, A Mirossay, J Mojzis Bioelectrochemistry 56 (1-2), 227-231, 2002 | 148 | 2002 |
| Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research A Kapinova, P Stefanicka, P Kubatka, P Zubor, S Uramova, M Kello, ... Biomedicine & Pharmacotherapy 96, 1465-1477, 2017 | 138 | 2017 |
| Antiangiogenic effect of flavonoids and chalcones: An update L Mirossay, L Varinská, J Mojžiš International journal of molecular sciences 19 (1), 27, 2017 | 135 | 2017 |
| Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism M Samec, A Liskova, L Koklesova, SM Samuel, K Zhai, C Buhrmann, ... Epma Journal 11, 377-398, 2020 | 114 | 2020 |
| Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro P Kubatka, S Uramova, M Kello, K Kajo, M Samec, K Jasek, D Vybohova, ... International journal of molecular sciences 20 (7), 1749, 2019 | 110 | 2019 |
| Oxidative stress, inflammation and colorectal cancer: an overview A Bardelčíková, J Šoltys, J Mojžiš Antioxidants 12 (4), 901, 2023 | 108 | 2023 |
| Hsp90 inhibitor as a sensitizer of cancer cells to different therapies Z Solárová, J MOJžiš, P SOLáR International journal of oncology 46 (3), 907-926, 2015 | 103 | 2015 |
| MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome M Cizmarikova, M Wagnerova, L Schonova, V Habalova, A Kohut, ... The pharmacogenomics journal 10 (1), 62-69, 2010 | 101 | 2010 |
| Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma P Kubatka, S Uramova, M Kello, K Kajo, P Kruzliak, J Mojzis, D Vybohova, ... Journal of Cellular and Molecular Medicine 21 (11), 2837-2851, 2017 | 97 | 2017 |
| In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues M Pilatova, L Varinska, P Perjesi, M Sarissky, L Mirossay, P Solar, A Ostro, ... Toxicology in Vitro 24 (5), 1347-1355, 2010 | 93 | 2010 |
| Antiproliferative and cancer chemopreventive activity of phytoalexins: focus on indole phytoalexins from crucifers. R Mezencev, J Mojzis, M Pilatova, P Kutschy Neoplasma 50 (4), 239-245, 2003 | 81 | 2003 |
| Protective effect of quercetin on ischemia/reperfusion-induced gastric mucosal injury in rats J Mojžiš, K Hviščová, D Germanova, D Bukovičová, L Mirossay Physiol. Res 50, 501-506, 2001 | 79 | 2001 |
| Cruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cells M Pilátová, M Šarišský, P Kutschy, A Miroššay, R Mezencev, Z Čurillová, ... Leukemia research 29 (4), 415-421, 2005 | 78 | 2005 |
| Antiproliferative effect of indole phytoalexins M Chripkova, F Zigo, J Mojzis Molecules 21 (12), 1626, 2016 | 77 | 2016 |
| Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses P Kubatka, M Kello, K Kajo, M Samec, K Jasek, D Vybohova, S Uramova, ... Molecules 25 (6), 1399, 2020 | 76 | 2020 |
| Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model P Kubatka, M Kello, K Kajo, P Kruzliak, D Výbohová, J Mojžiš, M Adamkov, ... European journal of nutrition 56, 1303-1316, 2017 | 75 | 2017 |
| Spirocyclization strategy toward indole phytoalexins. The first synthesis of (±)-1-methoxyspirobrassinin,(±)-1-methoxyspirobrassinol, and (±)-1-methoxyspirobrassinol methyl ether P Kutschy, M Suchý, K Monde, N Harada, R Marušková, Z Čurillová, ... Tetrahedron Letters 43 (52), 9489-9492, 2002 | 68 | 2002 |
